Surface analytical techniques in solid-state particle characterization for predicting performance in dry powder inhalers

KONA Powder and Particle Journal

Volumn 28, Issue , 2010, Pages 3-19

  Wu, Xiao ^a   Li, Xiaojian ^a   Mansour, Heidi M ^a  

^a Department of Pharmaceutical Sciences Drug Development Division1 ^*  (United States)

Author keywords

Inhalation aerosols; Interparticulate forces; Particle engineering; Pharmaceutical powders; Pulmonary drug delivery; Surface chemistry

Indexed keywords

AEROSOLS; ATOMIC FORCE MICROSCOPY; ATOMIZERS; BIOLOGICAL ORGANS; CHROMATOGRAPHY; DISEASE CONTROL; ELECTRIC IMPEDANCE; GAS CHROMATOGRAPHY; PROTEINS; PULMONARY DISEASES; SURFACE CHEMISTRY; SURFACE MORPHOLOGY; X RAY PHOTOELECTRON SPECTROSCOPY;

CHRONIC OBSTRUCTIVE PULMONARY DISEASE; INTERPARTICULATE FORCES; INVERSE GAS CHROMATOGRAPHY; MORPHOLOGY AND COMPOSITION; PARTICLE CHARACTERIZATION; PARTICLE ENGINEERING; PHARMACEUTICAL POWDER; PULMONARY DRUG DELIVERY;

SURFACE PROPERTIES;

EID: 79952932506     PISSN: 02884534     EISSN: 21875537     Source Type: Journal    
DOI: 10.14356/kona.2010005     Document Type: Review

References (184)

1. York, P. (1983): Solid-state Proper ties of Powders in the Formulation and Processing of Solid Dosage Forms, Int. J. Pharm., 14. pp.1-28.
2. Cui, Y. (2007): A Material Science Perspective of Pharmaceutical Solids, Int. J. Pharm., 339. pp.3-18.
3. Clas, S.D. (2003): The Importance of Characterizing the Crystal Form of the Drug Substance during Drug Development, Curr. Opin. Drug Discov. Devel., 6. pp.550-560.
4. Datta, S. and Grant, D.J. (2004): Crystal Structures of Drugs: Advances in Determination, Prediction and Engineering, Nat. Rev. Drug Discov., 3. pp.42-57.
5. Vippagunta, S.R., Brittain, H.G. and Grant, D.J. (2001): Crystalline Solids, Adv. Drug Deliv. Rev., 48. pp.3-26.
6. Hancock, B.C. and Zografi, G. (1997): Characteristics and Significance of the Amorphous State in Pharmaceutical Systems, J. Pharm. Sci., 86. pp.1-12.
7. Hilden, L.R. and Morris, K.R. (2004): Physics of Amorphous Solids, J. Pharm. Sci., 93. pp.3-12.
8. Kaushal, A.M., Gupta, P. and Bansal, A.K. (2004): Amorphous Drug Delivery Systems: Molecular Aspects, Design, and Performance, Crit. Rev. Ther. Drug Carrier Syst., 21. pp.133-193.
9. Yu, L. (2001): Amorphous Pharmaceutical Solids: Preparation, Characterization and Stabilization, Adv. Drug Deliv. Rev., 48. pp.27-42.
10. Rodriguez-Spong, B., Price, C.P., Jayasankar, A., Matzger, A.J. and Rodriguez-Hornedo, N. (2004): General Principles of Pharmaceutical Solid Polymorphism: A Supramolecular Perspective, Adv. Drug Deliv. Rev., 56. pp.241-274.
11. Singhal, D. and Curatolo, W. (2004): Drug Polymorphism and Dosage Form Design: A Practical Perspective, Adv. Drug Deliv. Rev., 56. pp.335-347.
12. Giron, D., Goldbronn, C., Mutz, M., Pfeffer, S., Piechon, P. and Schwab, P. (2002): Solid State Characterizations of Pharmaceutical Hydrates, J. Therm. Anal. Calorim., 68. pp.453-465.
13. Bouche, R. and Draguet-Brughmans, M. (1977): Polymorphism of Organic Drug Substances, J. Pharm. Belg., 32. pp.23-51.
14. Li, H., Kiang, Y.H. and Jona, J. (2009): Multiple Approaches to Pharmaceutical Polymorphism Investigation-A Case Study, Eur. J. Pharm. Sci., 38. pp.426-432.
15. Byrn, S.R. (1982): 'Solid State Chemistry of Drugs', Academic Press, New York.
16. Hilfiker, R. (2006): 'Polymorphism in the Pharmaceutical Industry', Wiley-VCH, Weinheim.
17. Haleblian, J. and McCrone, W. (1969): Pharmaceutical Applications of Polymorphism, J. Pharm. Sci., 58. pp.911-929.
18. Ghebremeskel, A.N., Vemavarapu, C. and Lodaya, M. (2007): Use of Surfactants as Plasticizers in Preparing Solid Dispersions of Poorly Soluble API: Selection of Polymer-surfactant Combinations Using Solubility Parameters and Testing the Processability, Int. J. Pharm., 328. pp.119-129.
19. Genina, N., Raikkonen, H., Ehlers, H., Heinamaki, J., Veski, P. and Yliruusi, J. (2010): Thin-coating as an Alternative Approach to Improve Flow Properties of Ibuprofen Powder, Int. J. Pharm., 387. pp.65-70.
20. Lee, Y.S., Poynter, R., Podczeck, F. and Newton, J.M. (2000): Development of a Dual Approach to Assess Powder Flow from Avalanching Behavior, AAPS PharmSci.Tech., 1. Article 21.
21. Builders, P.F., Ibekwe, N., Okpako, L.C., Attama, A.A. and Kunle, O.O. (2009): Preparation and Characterization of Mucinated Cellulose Microparticles for Therapeutic and Drug Delivery Purposes, Eur. J. Pharm. Biopharm., 72. pp.34-41.
22. Taylor, M.K., Ginsburg, J., Hickey, A. and Gheyas, F. (2000): Composite Method to Quantify Powder Flow as a Screening Method in Early Tablet or Capsule Formulation Development, AAPS PharmSci.Tech., 1. Article 18.
23. Hickey, A.J., Jackson, G.V. and Fildes, F.J. (1988): Preparation and Characterization of Disodium Fluorescein Powders in Association with Lauric and Capric Acids, J. Pharm. Sci., 77. pp.804-809.
24. Taylor, L.S. and Zografi, G. (1998): The Quantitative Analysis of Crystallinity Using FT-Raman Spectroscopy, Pharm. Res., 15. pp.755-761.
25. Newman, A.W. and Byrn, S.R. (2003): Solid-state Analysis of the Active Pharmaceutical Ingredient in Drug Products, Drug Discov. Today, 8. pp.898-905.
26. Hickey, A.J., Mansour, H.M., Telko, M.J., Xu, Z., Smyth, H.D., Mulder, T., McLean, R., Langridge, J. and Papadopoulos, D. (2007): Physical Characterization of Component Particles Included in Dry Powder Inhalers. I. Strategy Review and Static Characteristics, J. Pharm. Sci., 96. pp.1282-1301.
27. Strom, C.S. (1975): Indexing of Crystal Faces on Sem Photographs, Acta Crystallographica Section A, 31. pp.S216-S216.
28. Rebanta Bandyopadhyay and David J. W. Grant (2000): Influence of Crystal Habit on the Surface Free Energy and Interparticulate Bonding of L-Lysine Monohydrochloride Dihydrate, Pharm. Dev. Technol., 5. pp.27-37.
29. Muster, T.H. and Prestidge, C.A. (2002): Face Specific Sur face Proper ties of Pharmaceutical Crystals, J. Pharm. Sci., 91. pp.1432-1444.
30. Hancock, B.C. and Parks, M. (2000): What Is the True Solubility Advantage for Amorphous Pharmaceuticals?, Pharm. Res., 17. pp.397-404.
31. Dannenfelser, R.M., He, H., Joshi, Y., Bateman, S. and Serajuddin, A.T. (2004): Development of Clinical Dosage Forms for a Poorly Water Soluble Drug I: Application of Polyethylene Glycol-polysorbate 80 Solid Dispersion Carrier System, J. Pharm. Sci., 93. pp.1165-1175.
32. Craig, D.Q., Royall, P.G., Kett, V.L. and Hopton, M.L. (1999): The Relevance of the Amorphous State to Pharmaceutical Dosage Forms: Glassy Drugs and Freeze Dried Systems, Int. J. Pharm., 179. pp.179-207.
33. Gupta, M.K., Vanwert, A. and Bogner, R.H. (2003): Formation of Physically Stable Amorphous Drugs by Milling with Neusilin, J. Pharm. Sci., 92. pp.536-551.
34. Sharma, P., Denny, W.A. and Garg, S. (2009): Effect of Wet Milling Process on the Solid State of Indomethacin and Simvastatin, Int. J. Pharm., 380. pp.40-48.
35. Willart, J.F. and Descamps, M. (2008): Solid State Amorphization of Pharmaceuticals, Mol. Pharm., 5. pp.905-920.
36. Patterson, J.E., James, M.B., Forster, A.H., Lancaster, R.W., Butler, J.M. and Rades, T. (2005): The Influence of Thermal and Mechanical Preparative Techniques on the Amorphous State of Four Poorly Soluble Compounds, J. Pharm. Sci., 94. pp.1998-2012.
37. Gupta, P. and Bansal, A.K. (2005): Spray Drying for Generation of a Ternary Amorphous System of Celecoxib, PVP, and Meglumine, Pharm. Dev. Technol., 10. pp.273-281.
38. Healy, A.M., McDonald, B.F., Tajber, L. and Corrigan, O.I. (2008): Characterisation of Excipient-free Nanoporous Microparticles (NPMPs) of Bendroflumethiazide, Eur. J. Pharm. Biopharm., 69. pp.1182-1186.
39. Horvat, M., Mestrovic, E., Danilovski, A. and Craig, D.Q. (2005): An Investigation into the Thermal Behaviour of a Model Drug Mixture with Amorphous Trehalose, Int. J. Pharm., 294. pp.1-10.
40. Kim, J.S., Kim, M.S., Park, H.J., Jin, S.J., Lee, S. and Hwang, S.J. (2008): Physicochemical Properties and Oral Bioavailability of Amorphous Atorvastatin Hemicalcium Using Spray-drying and SAS Process, Int. J. Pharm., 359. pp.211-219.
41. Learoyd, T.P., Burrows, J.L., French, E. and Seville, P.C. (2008): Chitosan-based Spray-dried Respirable Powders for Sustained Delivery of Terbutaline Sulfate, Eur. J. Pharm. Biopharm., 68. pp.224-234.
42. Takeuchi, H., Nagira, S., Yamamoto, H. and Kawashima, Y. (2005): Solid Dispersion Particles of Amorphous Indomethacin with Fine Porous Silica Particles by Using Spray-drying Method, Int. J. Pharm., 293. pp.155-164.
43. Bhattacharya, S. and Suryanarayanan, R. (2009): Local Mobility in Amorphous Pharmaceuticals--Characterization and Implications on Stability, J. Pharm. Sci., 98. pp.2935-2953.
44. Liu, J. (2006): Physical Characterization of Pharmaceutical Formulations in Frozen and Freeze-dried Solid States: Techniques and Applications in Freeze-drying Development, Pharm. Dev. Technol., 11. pp.3-28.
45. Xiang, T.X. and Anderson, B.D. (2004): A Molecular Dynamics Simulation of Reactant Mobility in an Amorphous Formulation of a Peptide in Poly(vinylpyrrolidone), J. Pharm. Sci., 93. pp.855-876.
46. Bonacucina, G., Palmieri, G.F. and Craig, D.Q. (2005): Rheological and Dielectric Characterization of Monoolein/ water Mesophases in the Presence of a Peptide Drug, J. Pharm. Sci., 94. pp.2452-2462.
47. Efrat, R., Shalev, D.E., Hoffman, R.E., Aserin, A. and Garti, N. (2008): Effect of Sodium Diclofenac Loads on Mesophase Components and Structure, Langmuir, 24. pp.7590-7595.
48. Stevenson, C.L., Bennett, D.B. and Lechuga-Ballesteros, D. (2005): Pharmaceutical Liquid Crystals: The Relevance of Partially Ordered Systems, J. Pharm.Sci., 94. pp.1861-1880.
49. Descamps, M., Correia, N.T., Derollez, P., Danede, F. and Capet, F. (2005): Plastic and Glassy Crystal States of Caffeine, J. Phys. Chem. B, 109. pp.16092-16098.
50. Rey, R. (2008): Orientational Order and Rotational Relaxation in the Plastic Crystal Phase of Tetrahedral Molecules, J. Phys. Chem. B, 112. pp.344-357.
51. Singh, L.P. and Murthy, S.S. (2009): Dielectric and Calorimetric Investigation of an Unusual Two-component Plastic Crystal: Cyclohexanol-neopentylglycol, Phys. Chem. Chem. Phys., 11. pp.5110-5118.
52. Grebowicz, J., Cheng, S.Z.D. and Wunderlich, B. (1986): Kinetics of Transitions Involving Condis Crystals, J. POLYM. SCI. POL. PHYS., 24. pp.675-685.
53. Heinz, A., Strachan, C.J., Gordon, K.C. and Rades, T. (2009): Analysis of Solid-state Transformations of Pharmaceutical Compounds Using Vibrational Spectroscopy, J. Pharm. Pharmacol., 61. pp.971-988.
54. Bell, J.H., Hartley, P.S. and Cox, J.S. (1971): Dry Powder Aerosols. I. A New Powder Inhalation Device, J. Pharm. Sci., 60. pp.1559-1564.
55. Telko, M.J. and Hickey, A.J. (2005): Dry Powder Inhaler Formulation, Respir. Care, 50. pp.1209-1227.
56. Andya, J.D., Maa, Y.F., Costantino, H.R., Nguyen, P.A., Dasovich, N., Sweeney, T.D., Hsu, C.C. and Shire, S.J. (1999): The Effect of Formulation Excipients on Protein Stability and Aerosol Performance of Spraydried Powders of a Recombinant Humanized Anti-IgE Monoclonal Antibody, Pharm. Res., 16. pp.350-358.
57. Clarke, M.J., Tobyn, M.J. and Staniforth, J.N. (2000): Physicochemical Factors Governing the Performance of Nedocromil Sodium as a Dry Powder Aerosol, J. Pharm. Sci., 89. pp.1160-1169.
58. Costantino, H.R., Andya, J.D., Nguyen, P.A., Dasovich, N., Sweeney, T.D., Shire, S.J., Hsu, C.C. and Maa, Y.F. (1998): Effect of Mannitol Crystallization on the Stability and Aerosol Performance of a Spray-dried Pharmaceutical Protein, Recombinant Humanized Anti-IgE Monoclonal Antibody, J. Pharm. Sci., 87. pp.1406-1411.
59. Junghanns, J.U. and Muller, R.H. (2008): Nanocrystal Technology, Drug Delivery and Clinical Applications, Int. J. Nanomedicine, 3. pp.295-309.
60. Merisko-Liversidge, E., Liversidge, G.G. and Cooper, E.R. (2003): Nanosizing: A Formulation Approach for Poorly-water-soluble Compounds, Eur. J. Pharm. Sci., 18. pp.113-120.
61. Merisko-Liversidge, E., Sarpotdar, P., Bruno, J., Hajj, S., Wei, L., Peltier, N., Rake, J., Shaw, J.M., Pugh, S., Polin, L., Jones, J., Corbett, T., Cooper, E. and Liversidge, G.G. (1996): Formulation and Antitumor Activity Evaluation of Nanocrystalline Suspensions of Poorly Soluble Anticancer Drugs, Pharm. Res., 13. pp.272-278.
62. Xu, Z., Mansour, H.M., Mulder, T., McLean, R., Langridge, J. and Hickey, A.J. (2010): Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 1. albuterol sulfate and disodium cromoglycate, J. Pharm. Sci., 99. pp.3398-3414.
63. Xu, Z., Mansour, H.M., Mulder, T., McLean, R., Langridge, J. and Hickey, A.J. (2010): Dry powder aerosols generated by standardized entrainment tubes from drug blends with lactose monohydrate: 2. Ipratropium bromide monohydrate and fluticasone propionate, J. Pharm. Sci., 99. pp.3415-3429.
64. Xu, Z., Mansour, H.M., Mulder, T., McLean, R., Langridge, J. and Hickey, A.J. (2010): Heterogeneous particle deaggregation and its implication for therapeutic aerosol performance, J. Pharm. Sci., 99. pp.3442-3461.
65. Mansour, H.M., Xu, Z. and Hickey, A.J. (2010): Dry powder aerosols generated by standardized entrainment tubes from alternative sugar blends: 3. Trehalose dihydrate and D-mannitol carriers, J. Pharm. Sci., 99. pp.3430-3441.
66. Atkins, P.J. (2005): Dry Powder Inhalers: an Overview, Respir. Care, 50. pp.1304-1312; discussion 1312.
67. Hickey, A.J. and Mansour, H.M., Chapter 5: Delivery of Drugs by the Pulmonary Route, in Modern Pharmaceutics, A.T. Florence and J. Siepmann, Editors. 2009, Taylor and Francis, Inc: New York. p. 191-219.
68. Geller, D.E. (2005): Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler, Respir Care, 50. pp.1313-1321; discussion 1321-2.
69. Kleinstreuer, C., Zhang, Z. and Donohue, J.F. (2008): Targeted Drug-Aerosol Delivery in the Human Respiratory System, Annu. Rev. Biomed. Eng., 10. pp.195-220.
70. Xu, Z., Mansour, H.M., Mulder, T., McLean, R., Langridge, J. and Hickey, A.J., Comparative Dispersion Study of Dry Powder Aerosols of Albuterol Sulfate/ Lactose Monohydrate and Cromolyn Sodium/Lactose Monohydrate Delivered by Standardized Entrainment Tubes, in Respiratory Drug Delivery XI, R.N. Dalby, et al., Editors. 2008, Davis Healthcare International Publishing, LLC: Scotsdale, Arizona. p. 897-900.
71. Young, P.M., Kwok, P., Adi, H., Chan, H.K. and Traini, D. (2009): Lactose composite carriers for respiratory delivery, Pharm Res, 26. pp.802-810.
72. Hickey, A.J., Mansour, H.M., Telko, M.J., Xu, Z., Smyth, H.D.C., Mulder, T., McLean, R., Langridge, J. and Papadopoulous, D. (2007): Physical Characterization of Component Particles included in Dry Powder Inhalers: II. Dynamic Characteristics, J Pharm Sci, 96. pp.1302-1319.
73. Hickey, A.J. and Mansour, H.M., Chapter 43: Formulation Challenges of Powders for the Delivery of Small Molecular Weight Molecules as Aerosols., in Modified-Release Drug Delivery Technology, M.J. Rathbone, et al., Editors. 2008, Informa Healthcare: New York. p. 573-602.
74. Montreal protocol 1987. Montreal protocol on substances that deplete the ozone layers, 1987.
75. Newman, S.P. and Clarke, S.W. (1993): Bronchodilator Delivery from Gentlehaler, a New Low-Velocity Pressurized Aerosol Inhaler, Chest, 103. pp.1442-1446.
76. Ganderton, D. (1997): General Factors Influencing Drug Delivery to the Lung, Respir. Med., 91 Suppl A. pp.13-16.
77. Newman, S.P. and Newhouse, M.T. (1996): Effect of Add-on Devices for Aerosol Drug Delivery: Deposition Studies and Clinical Aspects, J. Aerosol Med., 9. pp.55-70.
78. Borgstrom, L., Derom, E., Stahl, E., Wahlin-Boll, E. and Pauwels, R. (1996): The Inhalation Device Influences Lung Deposition and Bronchodilating Effect of Terbutaline, Am. J. Respir. Crit. Care Med., 153. pp.1636-1640.
79. Telko, M.J. and Hickey, A.J. (2005): Dry Powder Inhaler Formulation, Respir. Care, 50. pp.1209-1227.
80. Ashurst, I.I., Malton, A., Prime, D. and Sumby, B. (2000): Latest Advances in the Development of Dry Powder Inhalers, Pharm. Sci. Technolo. Today, 3. pp.246-256.
81. Norwood, D.L., Prime, D., Downey, B.P., Creasey, J., Sethi, S.K. and Haywood, P. (1995): Analysis of Polycyclic Aromatic Hydrocarbons in Metered Dose Inhaler Drug Formulations by Isotope Dilution Gas Chromatography/ Mass Spectrometry, J. Pharm. Biomed. Anal., 13. pp.293-304.
82. Howarth, P.H. (1997): What is the Nature of Asthma and Where are the Therapeutic Targets?, Respir. Med., 91 Suppl A. pp.2-8.
83. Carstairs, J.R., Nimmo, A.J. and Barnes, P.J. (1985): Autoradiographic Visualization of Beta-Adrenoceptor Subtypes in Human Lung, Am. Rev. Respir. Dis., 132. pp.541-547.
84. Barnes, P.J., Basbaum, C.B., Nadel, J.A. and Roberts, J.M. (1982): Localization of Beta-Adrenoreceptors in Mammalian Lung by Light Microscopic Autoradiography, Nature, 299. pp.444-447.
85. Labiris, N.R. and Dolovich, M.B. (2003): Pulmonary Drug Delivery. Part I: Physiological Factors Affecting Therapeutic Effectiveness of Aerosolized Medications, Br. J. Clin. Pharmacol., 56. pp.588-599.
86. Pedersen, S. and O'Byrne, P. (1997): A Comparison of the Efficacy and Safety of Inhaled Corticosteroids in Asthma, Allergy, 52. pp.1-34.
87. Leach, C.L., Davidson, P.J. and Boudreau, R.J. (1998): Improved Airway Targeting with the CFC-Free HFABeclomethasone Metered-Dose Inhaler Compared with CFC-Beclomethasone, Eur. Respir. J., 12. pp.1346-1353.
88. Barnes, P.J., Basbaum, C.B. and Nadel, J.A. (1983): Autoradiographic Localization of Autonomic Receptors in Airway Smooth Muscle. Marked Differences between Large and Small Airways, Am. Rev. Respir. Dis., 127. pp.758-762.
89. Irngartinger, M., Camuglia, V., Damm, M., Goede, J. and Frijlink, H.W. (2004): Pulmonary Delivery of Therapeutic Peptides via Dr y Powder Inhalation: Effects of Micronisation and Manufacturing, Eur. J. Pharm. Biopharm., 58. pp.7-14.
90. Steckel, H., Markefka, P., teWierik, H. and Kammelar, R. (2006): Effect of Milling and Sieving on Functionality of Dry Powder Inhalation Products, Int. J. Pharm., 309. pp.51-59.
91. Rasenack, N. and Muller, B.W. (2004): Micron-Size Drug Particles: Common and Novel Micronization Techniques, Pharm. Dev. Technol., 9. pp.1-13.
92. Dunbar, C.H.A., Hickey, A.J. and Holzner, P. (1998): Dispersion and Characterization of Pharmaceutical Dry Powder Aerosols, KONA Powder Part., 16. pp.7-45.
93. Mosen, K., Backstrom, K., Thalberg, K., Schaefer, T., Kristensen, H.G. and Axelsson, A. (2004): Particle Formation and Capture during Spray Drying of Inhalable Particles, Pharm. Dev. Technol., 9. pp.409-417.
94. Seville, P.C., Li, H.Y. and Learoyd, T.P. (2007): Spray-Dried Powders for Pulmonary Drug Delivery, Crit. Rev. Ther. Drug Carrier Syst., 24. pp.307-360.
95. Weers, J.G., Tarara, T.E. and Clark, A.R. (2007): Design of Fine Particles for Pulmonary Drug Delivery, Expert Opin. Drug Deliv., 4. pp.297-313.
96. Tom, J.W. and Debenedetti, P.G. (1991): Particle formation with supercritical fluids--a review, J Aerosol Sci, 22. pp.555-584.
97. Chow, A.H., Tong, H.H., Chattopadhyay, P. and Shekunov, B.Y. (2007): Particle Engineering for Pulmonary Drug Delivery, Pharm. Res., 24. pp.411-437.
98. Mansour, H.M., Rhee, Y.S. and Wu, X. (2009): Nanomedicine in Pulmonary Delivery, Int. J. Nanomedicine, 4. pp.299-319.
99. Ozeki, T., Beppu, S., Mizoe, T., Takashima, Y., Yuasa, H. and Okada, H. (2006): Preparation of Polymeric Submicron Particle-Containing Microparticles Using a 4-Fluid Nozzle Spray Drier, Pharm. Res., 23. pp.177-183.
100. Elversson, J. and Millqvist-Fureby, A. (2005): Particle Size and Density in Spray Drying-Effects of Carbohydrate Properties, J. Pharm. Sci., 94. pp.2049-2060.
101. White, S., Bennett, D.B., Cheu, S., Conley, P.W., Guzek, D.B., Gray, S., Howard, J., Malcolmson, R., Parker, J.M., Roberts, P., Sadrzadeh, N., Schumacher, J.D., Seshadri, S., Sluggett, G.W., Stevenson, C.L. and Harper, N.J. (2005): EXUBERA: Pharmaceutical De velopment of a Novel Product for Pulmonary Delivery of Insulin, Diabetes Technol. Ther., 7. pp.896-906.
102. Gilani, K., Najafabadi, A.R., Barghi, M. and Rafiee-Tehrani, M. (2005): The Effect of Water to Ethanol Feed Ratio on Physical Properties and Aerosolization Behavior of Spray Dried Cromolyn Sodium Particles, J. Pharm. Sci., 94. pp.1048-1059.
103. Vidgren, M.T., Vidgren, P.A. and Paronen, T.P. (1987): Comparison of Physical and Inhalation Properties of Spray-Dried and Mechanically Micronized Disodium Cromoglycate, Int. J. Pharm., 35. pp.139-144.
104. Chattopadhyay, P., Shekunov, B.Y., Yim, D., Cipolla, D., Boyd, B. and Farr, S. (2007): Production of Solid Lipid Nanoparticle Suspensions Using Supercritical Fluid Extraction of Emulsions (SFEE) for Pulmonary Delivery Using the AERx System, Adv. Drug Deliv. Rev., 59. pp.444-453.
105. Tom, J.W. and Debenedetti, P.G. (1991): Particle Formation with Supercritical Fluids--a Review, J. Aerosol Sci., 22. pp.555-584.
106. Rehman, M., Shekunov, B.Y., York, P., Lechuga-Ballesteros, D., Miller, D.P., Tan, T. and Colthorpe, P. (2004): Optimisation of Powders for Pulmonary Delivery Using Supercritical Fluid Technology, Eur. J. Pharm. Sci., 22. pp.1-17.
107. Steckel, H., Thies, J. and Muller, B.W. (1997): Micronizing of Steroids for Pulmonary Delivery by Supercritical Carbon Dioxide, Int. J. Pharm., 152. pp.99-110.
108. Steckel, H. and Muller, B.W. (1998): Metered-Dose Inhaler Formulation of Fluticasone-17-Propionate Micronized with Supercritical Carbon Dioxide Using the Alternative Propellant HFA-227, Int. J. Pharm., 173. pp.25-33.
109. Shekunov, B.Y., Chattopadhyay, P., Seitzinger, J. and Huff, R. (2006): Nanoparticles of Poorly Water-Soluble Drugs Prepared by Supercritical Fluid Extraction of Emulsions, Pharm. Res., 23. pp.196-204.
110. Chattopadhyay, P., Huff, R. and Shekunov, B.Y. (2006): Drug Encapsulation Using Supercritical Fluid Extraction of Emulsions, J. Pharm. Sci., 95. pp.667-679.
111. Rasenack, N. and Muller, B.W. (2004): Micron-Size Drug Particles: Common and Novel Micronization Techniques, Pharm. Dev. Technol., 9. pp.1-13.
112. Concessio, N.M. and Hickey, A.J. (1994): Assessment of Micronized Powders Dispersed as Aerosols, Pharm. Tech., 18. pp.88-98.
113. Newman, S.P. and Busse, W.W. (2002): Evolution of Dry Powder Inhaler Design, Formulation, and Performance, Respir. Med., 96. pp.293-304.
114. Steckel, H. and Bolzen, N. (2004): Alternative Sugars as Potential Carriers for Dry Powder Inhalations, Int. J. Pharm., 270. pp.297-306.
115. Harjunen, P., Lankinen, T., Salonen, H., Lehto, V.P. and Jarvinen, K. (2003): Effects of Carriers and Storage of Formulation on the Lung Deposition of a Hydrophobic and Hydrophilic Drug from a DPI, Int. J. Pharm., 263. pp.151-163.
116. Vanbever, R., Mintzes, J.D., Wang, J., Nice, J., Chen, D., Batycky, R., Langer, R. and Edwards, D.A. (1999): Formulation and Physical Characterization of Large Porous Par ticles for Inhalation, Pharm. Res., 16. pp.1735-1742.
117. Steckel, H. and Brandes, H.G. (2004): A Novel Spray-Drying Technique to Produce Low Density Particles for Pulmonary Delivery, Int. J. Pharm., 278. pp.187-195.
118. Chew, N.Y. and Chan, H.K. (2001): Use of Solid Corrugated Particles to Enhance Powder Aerosol Performance, Pharm. Res., 18. pp.1570-1577.
119. Maa, Y.F., Costantino, H.R., Nguyen, P.A. and Hsu, C.C. (1997): The Effect of Operating and Formulation Variables on the Morphology of Spray-Dried Protein Particles, Pharm. Dev. Technol., 2. pp.213-223.
120. Chew, N.Y., Tang, P., Chan, H.K. and Raper, J.A. (2005): How Much Particle Surface Corrugation is Sufficient to Improve Aerosol Performance of Powders?, Pharm. Res., 22. pp.148-152.
121. Coates, M.S., Chan, H.K., Fletcher, D.F. and Raper, J.A. (2005): Influence of Air Flow on the Performance of a Dry Powder Inhaler Using Computational and Experimental Analyses, Pharm. Res., 22. pp.1445-1453.
122. Chan, H.K. (2006): Dry Powder Aerosol Delivery Systems: Current and Future Research Directions, J. Aerosol Med., 19. pp.21-27.
123. Edwards, D.A. and Dunbar, C. (2002): Bioengineering of Therapeutic Aerosols, Annu. Rev. Biomed. Eng., 4. pp.93-107.
124. Dolovich, M.B., Ahrens, R.C., Hess, D.R., Anderson, P., Dhand, R., Rau, J.L., Smaldone, G.C. and Guyatt, G. (2005): Device Selection and Outcomes of Aerosol Therapy: Evidence-Based Guidelines: American College of Chest Physicians/American College of Asthma, Allergy, and Immunology, Chest, 127. pp.335-371.
125. Heng, J.Y., Bismarck, A., Lee, A.F., Wilson, K. and Williams, D.R. (2006): Anisotropic Surface Energetics and Wettability of Macroscopic Form I Paracetamol Crystals, Langmuir, 22. pp.2760-2769.
126. Eaton, P., Estarlich, F.F., Ewen, R.J., Nevell, T.G., Smith, J.R. and Tsibouklis, J. (2002): Combined Nanoindentation and Adhesion Force Mapping Using the Atomic Force Microscope: Investigations of a Filled Polysiloxane Coating, Langmuir, 18. pp.10011-10015.
127. El-Sabawi, D., Price, R., Edge, S. and Young, P.M. (2006): Novel Temperature Controlled Surface Dissolution of Excipient Particles for Carrier Based Dry Powder Inhaler Formulations, Drug Dev. Ind. Pharm., 32. pp.243-251.
128. Traini, D., Young, P.M., Jones, M., Edge, S. and Price, R. (2006): Comparative Study of Erythritol and Lactose Monohydrate as Carriers for Inhalation: Atomic Force Microscopy and in Vitro Correlation, Eur. J. Pharm. Sci., 27. pp.243-251.
129. Zeng, X.M., Martin, A.P., Marriott, C. and Pritchard, J. (2000): The Influence of Carrier Morphology on Drug Delivery by Dry Powder Inhalers, Int. J. Pharm., 200. pp.93-106.
130. Young, P.M., Cocconi, D., Colombo, P., Bettini, R., Price, R., Steele, D.F. and Tobyn, M.J. (2002): Characterization of a Surface Modified Dry Powder Inhalation Carrier Prepared by 'Particle Smoothing', J. Pharm. Pharmacol., 54. pp.1339-1344.
131. Fults, K.A., Miller, I.F. and Hickey, A.J. (1997): Effect of Particle Morphology on Emitted Dose of Fatty Acid-Treated Disodium Cromoglycate Powder Aerosols, Pharm. Dev. Technol., 2. pp.67-79.
132. Heng, P.W. and Staniforth, J.N. (1988): The Effect of Moisture on the Cohesive Properties of Microcrystalline Celluloses, J. Pharm. Pharmacol., 40. pp.360-362.
133. Bunker, M.J., Davies, M.C., Chen, X., James, M.B. and Roberts, C.J. (2006): Single Particle Friction on Blister Packaging Materials Used in Dry Powder Inhalers, Eur. J. Pharm. Sci., 29. pp.405-413.
134. Traini, D., Young, P.M., Rogueda, P. and Price, R. (2006): Investigation into the Influence of Polymeric Stabilizing Excipients on Inter-particulate Forces in Pressurised Metered Dose Inhalers, Int. J. Pharm., 320. pp.58-63.
135. Eve, J.K., Patel, N., Luk, S.Y., Ebbens, S.J. and Roberts, C.J. (2002): A Study of Single Drug Particle Adhesion Interactions Using Atomic Force Microscopy, Int. J. Pharm., 238. pp.17-27.
136. Berard, V., Lesniewska, E., Andres, C., Pertuy, D., Laroche, C. and Pourcelot, Y. (2002): Affinity Scale between a Carrier and a Drug in DPI Studied by Atomic Force Microscopy, Int. J. Pharm., 247. pp.127-137.
137. Heinz, W.F. and Hoh, J.H. (1999): Spatially Resolved Force Spectroscopy of Biological Surfaces Using the Atomic Force Microscope, Trends Biotechnol., 17. pp.143-150.
138. Binnig, G., Quate, C.F. and Gerber, C. (1986): Atomic Force Microscope, Phys. Rev. Lett., 56. pp.930-933.
139. Duddu, S.P., Sisk, S.A., Walter, Y.H., Tarara, T.E., Trimble, K.R., Clark, A.R., Eldon, M.A., Elton, R.C., Pickford, M., Hirst, P.H., Newman, S.P. and Weers, J.G. (2002): Improved Lung Delivery from a Passive Dry Powder Inhaler Using an Engineered PulmoSphere Powder, Pharm. Res., 19. pp.689-695.
140. Dellamary, L.A., Tarara, T.E., Smith, D.J., Woelk, C.H., Adractas, A., Costello, M.L., Gill, H. and Weers, J.G. (2000): Hollow Porous Particles in Metered Dose Inhalers, Pharm. Res., 17. pp.168-174.
141. Edwards, D.A., Hanes, J., Caponetti, G., Hrkach, J., Ben-Jebria, A., Eskew, M.L., Mintzes, J., Deaver, D., Lotan, N. and Langer, R. (1997): Large Porous Particles for Pulmonary Drug Delivery, Science, 276. pp.1868-1871.
142. Adi, S., Adi, H., Tang, P., Traini, D., Chan, H.K. and Young, P.M. (2008): Micro-Particle Corrugation, Adhesion and Inhalation Aerosol Efficiency, Eur. J. Pharm. Sci., 35. pp.12-18.
143. Young, P.M., Price, R., Tobyn, M.J., Buttrum, M. and Dey, F. (2003): Investigation into the Effect of Humidity on Drug-Drug Interactions Using the Atomic Force Microscope, J. Pharm. Sci., 92. pp.815-822.
144. Davies, M.J., Brindley, A., Chen, X., Doughty, S.W., Marlow, M. and Roberts, C.J. (2009): A Quantitative Assessment of Inhaled Drug Particle-Pulmonary Surfactant Interaction by Atomic Force Microscopy, Colloids Surf. B Biointerfaces, 73. pp.97-102.
145. Begat, P., Morton, D.A., Staniforth, J.N. and Price, R. (2004): The Cohesive-Adhesive Balances in Dry Powder Inhaler Formulations I: Direct Quantification by Atomic Force Microscopy, Pharm. Res., 21. pp.1591-597.
146. Hooton, J.C., Jones, M.D. and Price, R. (2006): Predicting the Behavior of Novel Sugar Carriers for Dry Powder Inhaler Formulations via the Use of a Cohesive-Adhesive Force Balance Approach, J. Pharm. Sci., 95. pp.1288-1297.
147. Hooton, J.C., Jones, M.D., Harris, H., Shur, J. and Price, R. (2008): The Influence of Crystal Habit on the Prediction of Dry Powder Inhalation Formulation Performance Using the Cohesive-Adhesive Force Balance Approach, Drug Dev. Ind. Pharm., 34. pp.974-983.
148. Danesh, A., Chen, X., Davies, M.C., Roberts, C.J., Sanders, G.H. and Tendler, S.J. (2000): Polymorphic Discrimination Using Atomic Force Microscopy: Distinguishing between Two Polymorphs of the Drug Cimetidine, Langmuir, 16. pp.866-870.
149. Trojak, A., Kocevar, K., Musevic, I. and Srcic, S. (2001): Investigation of the Felodipine Glassy State by Atomic Force Microscopy, Int. J. Pharm., 218. pp.145-151.
150. Hooton, J.C., German, C.S., Allen, S., Davies, M.C., Roberts, C.J., Tendler, S.J. and Williams, P. (2003): Characterization of Particle-Interactions by Atomic Force Microscopy: Effect of Contact Area, Pharm. Res., 20. pp.508-514.
151. Louey, M.D. and Stewart, P.J. (2002): Particle Interactions Involved in Aerosol Dispersion of Ternary Interactive Mixtures, Pharm. Res., 19. pp.1524-1531.
152. Louey, M.D., Mulvaney, P. and Stewart, P.J. (2001): Characterisation of Adhesional Properties of Lactose Carriers Using Atomic Force Microscopy, J. Pharm. Biomed. Anal., 25. pp.559-567.
153. Dai, X., Reading, M. and Craig, D.Q. (2009): Mapping Amorphous Material on a Partially Crystalline Surface: Nanothermal Analysis for Simultaneous Characterisation and Imaging of Lactose Compacts, J. Pharm. Sci., 98. pp.1499-1510.
154. Harding, L., King, W.P., Dai, X., Craig, D.Q. and Reading, M. (2007): Nanoscale Characterisation and Imaging of Partially Amorphous Materials Using Local Thermomechanical Analysis and Heated Tip AFM, Pharm. Res., 24. pp.2048-2054.
155. Nelson, B.A. and King, W.P. (2007): Measuring Material Softening with Nanoscale Spatial Resolution Using Heated Silicon Probes, Rev. Sci. Instrum., 78. p023702.
156. Ye, J., Reading, M., Gotzen, N. and Van Assche, G. (2007): Scanning Thermal Probe Microscopy: Nanothermal Analysis with Raman Microscopy, Microsc. Anal., 21. pp.S5-S8.
157. Reading, M., Price, D.M., Grandy, D.B., Smith, R.M., Bozec, L., Conroy, M., Hammiche, A. and Pollock, H.M. (2001): Micro-Thermal Analysis of Polymers: Current Capabilities and Future Prospects, Macromol. Symp., 167. pp.45-62.
158. Tsukruk, V.V., Gorbunov, V.V. and Fuchigami, N. (2002): Microthermal Analysis of Polymeric Materials, Thermochim. Acta, 395. pp.151-158.
159. Pollock, H.M. and Hammiche, A. (2001): Micro-Thermal Analysis: Techniques and Applications, J. Phys. D: Appl. Phys., 34. pp.R23-R53.
160. Brown, E., Hao, L., Cox, D.C. and Gallop, J.C. (2008): Scanning Thermal Microscopy Probe Capable of Simultaneous Electrical Imaging and the Addition of a Diamond Tip, J. Phys.: Confer. Ser., 100. p052012.
161. Sedman, V.L., Allen, S., Chen, X., Roberts, C.J. and Tendler, S.J. (2009): Thermomechanical Manipulation of Aromatic Peptide Nanotubes, Langmuir, 25. pp.7256-7259.
162. Murphy, J.R., Andrews, C.S. and Craig, D.Q. (2003): Characterization of the Thermal Properties of Powder Particles Using Microthermal Analysis, Pharm. Res., 20. pp.500-507.
163. Wu, J., Reading, M. and Craig, D.Q. (2008): Application of Calorimetry, Sub-Ambient Atomic Force Microscopy and Dynamic Mechanical Analysis to the Study of Frozen Aqueous Trehalose Solutions, Pharm. Res., 25. pp.1396-1404.
164. Zhang, J., Bunker, M., Chen, X., Parker, A.P., Patel, N. and Roberts, C.J. (2009): Nanoscale Thermal Analysis of Pharmaceutical Solid Dispersions, Int. J. Pharm., 380. pp.170-173.
165. Buckton, G., Ambarkhane, A. and Pincott, K. (2004): The Use of Inverse Phase Gas Chromatography to Study the Glass Transition Temperature of a Powder Surface, Pharm. Res., 21. pp.1554-1557.
166. Tong, H.H., Shekunov, B.Y., York, P. and Chow, A.H. (2006): Predicting the Aerosol Performance of Dry Powder Inhalation Formulations by Interparticulate Interaction Analysis Using Inverse Gas Chromatography, J. Pharm. Sci., 95. pp.228-233.
167. Columbano, A., Buckton, G. and Wikeley, P. (2003): Characterisation of Sur face Modified Salbutamol Sulphate-Alkylpolyglycoside Microparticles Prepared by Spray Drying, Int. J. Pharm., 253. pp.61-70.
168. Newell, H.E. and Buckton, G. (2004): Inverse Gas Chromatography: Investigating Whether the Technique Preferentially Probes High Energy Sites for Mixtures of Cr ystalline and Amorphous Lactose, Pharm. Res., 21. pp.1440-1444.
169. Buckton, G. and Gill, H. (2007): The Importance of Surface Energetics of Powders for Drug Delivery and the Establishment of Inverse Gas Chromatography, Adv. Drug Deliv. Rev., 59. pp.1474-1479.
170. Ticehurst, M.D., York, P., Rowe, R.C. and Dwivwdi, S.K. (1994): Determination of the Surface Properties of Two Batches of Salbutamol Sulphate by Inverse Gas Chromatography, Int. J. Pharm., 111. pp.241-249.
171. York, P., Ticehurst, M.D., Osborn, J.C., Roberts, R.J. and Rowe, R.C. (1998): Characterisation of the Surface Energetics of Milled dl-Propranolol Hydrochloride Using Inverse Gas Chromatography and Molecular Modelling, Int. J. Pharm., 174. pp.179-186.
172. Feeley, J.C., York, P., Sumby, B.S. and Dicks, H. (1998): Determination of Surface Properties and Flow Characteristics of Salbutamol Sulphate, before and after Micronisation, Int. J. Pharm., 172. pp.89-96.
173. Sunkersett, M.R., Grimsey, I.M., Doughty, S.W., Osborn, J.C., York, P. and Rowe, R.C. (2001): The Changes in Surface Energetics with Relative Humidity of Carbamazepine and Paracetamol as Measured by Inverse Gas Chromatography, Eur. J. Pharm. Sci., 13. pp.219-225.
174. Newell, H.E., Buckton, G., Butler, D.A., Thielmann, F. and Williams, D.R. (2001): The Use of Inverse Phase Gas Chromatography to Study the Change of Surface Energy of Amorphous Lactose as a Function of Relative Humidity and the Processes of Collapse and Crystallisation, Int. J. Pharm., 217. pp.45-56.
175. Tong, H.H., Shekunov, B.Y., York, P. and Chow, A.H. (2001): Characterization of Two Polymorphs of Salmeterol Xinafoate Crystallized from Supercritical Fluids, Pharm. Res., 18. pp.852-858.
176. Tong, H.H., Shekunov, B.Y., York, P. and Chow, A.H. (2002): Influence of Polymorphism on the Surface Energetics of Salmeterol Xinafoate Crystallized from Supercritical Fluids, Pharm. Res., 19. pp.640-648.
177. Ohta, M. and Buckton, G. (2004): The Use of Inverse Gas Chromatography to Assess the Acid-Base Contributions to Surface Energies of Cefditoren Pivoxil and Methacrylate Copolymers and Possible Links to Instability, Int. J. Pharm., 272. pp.121-128.
178. Grimsey, I.M., Feeley, J.C. and York, P. (2002): Analysis of the Surface Energy of Pharmaceutical Powders by Inverse Gas Chromatography, J. Pharm. Sci., 91. pp.571-583.
179. Ohta, M. and Buckton, G. (2004): Determination of the Changes in Surface Energetics of Cefditoren Pivoxil as a Consequence of Processing Induced Disorder and Equilibration to Different Relative Humidities, Int. J. Pharm., 269. pp.81-88.
180. Ambarkhane, A.V., Pincott, K. and Buckton, G. (2005): The Use of Inverse Gas Chromatography and Gravimetric Vapour Sorption to Study Transitions in Amorphous Lactose, Int. J. Pharm., 294. pp.129-135.
181. Voelkel, A., Strzemiecka, B., Adamska, K. and Milczewska, K. (2009): Inverse Gas Chromatography as a Source of Physiochemical Data, J. Chromatogr. A, 1216. pp.1551-1566.
182. Charmas, B. and Leboda, R. (2000): Effect of Surface Heterogeneity on Adsorption on Solid Surfaces. Application of Inverse Gas Chromatography in the Studies of Energetic Heterogeneity of Adsorbents, J. Chromatogr. A, 886. pp.133-152.
183. Thielmann, F. (2004): Introduction into the Characterisation of Porous Materials by Inverse Gas Chromatography, J. Chromatogr. A., 1037. pp.115-123.
184. Bosquillon, C., Rouxhet, P.G., Ahimou, F., Simon, D., Culot, C., Preat, V. and Vanbever, R. (2004): Aerosolization Properties, Surface Composition and Physical State of Spray-Dried Protein Powders, J. Control. Release, 99. pp.357-367.